Biotech Shorts: Bluebird’s Zynteglo, a beta-thalassemia gene therapy, safety issue could prove problematic for gene therapies

Bluebird’s Zynteglo safety snag could spell trouble for other gene therapies, say analysts. Bluebird Bio’s one-time blood disorder gene therapy…

Copyright © Gowing Life Limited, 2023 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.